Ritonavir Terminated Phase 4 Trials for Acute HIV Infection / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00855413HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT00420355Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
NCT00386659Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.
NCT00234962Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy
NCT01118871The First Failure Study
NCT00765154NNRTI/PI Toxicity Switch to Darunavir Study
NCT00661349Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients
NCT00632970Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals
NCT00531986HIV - Monotherapy in Switzerland (MOST-ch)
NCT00679926Kaletra and Viread in Antiretroviral Naïve Patients
NCT01068873Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
NCT00414284BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)